Antibiotic treatment of biofilm infections.
Reads0
Chats0
TLDR
The current knowledge on phenotypic and genetic resistance in biofilms is reviewed, the potential strategies for the antibiotic treatment of biofilm infections are described and the optimization of PK/PD parameters in bio Films, high‐dose topical treatments, combined and sequential/alternate therapies or the use antibiotic adjuvants are described.Abstract:
Bacterial biofilms are associated with a wide range of infections, from those related to exogenous devices, such as catheters or prosthetic joints, to chronic tissue infections such as those occurring in the lungs of cystic fibrosis patients. Biofilms are recalcitrant to antibiotic treatment due to multiple tolerance mechanisms (phenotypic resistance). This causes persistence of biofilm infections in spite of antibiotic exposure which predisposes to antibiotic resistance development (genetic resistance). Understanding the interplay between phenotypic and genetic resistance mechanisms acting on biofilms, as well as appreciating the diversity of environmental conditions of biofilm infections which influence the effect of antibiotics are required in order to optimize the antibiotic treatment of biofilm infections. Here, we review the current knowledge on phenotypic and genetic resistance in biofilms and describe the potential strategies for the antibiotic treatment of biofilm infections. Of note is the optimization of PK/PD parameters in biofilms, high-dose topical treatments, combined and sequential/alternate therapies or the use antibiotic adjuvants.read more
Citations
More filters
Journal ArticleDOI
Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents-How P. aeruginosa Can Escape Antibiotics
Oana Ciofu,Tim Tolker-Nielsen +1 more
TL;DR: In this review, both the antimicrobial tolerance and the development of resistance to antibiotics in P. aeruginosaBiofilms are discussed and possible therapeutic approaches based on the understanding of the mechanisms involved in the tolerance and resistances of biofilms to antibiotics are addressed.
Journal ArticleDOI
Biofilm-related disease.
TL;DR: ABSTRACT Biofilm formation represents a protected mode of growth that renders bacterial cells less susceptible to antimicrobials and to killing by host immune effector mechanisms and s...
Journal ArticleDOI
Antimicrobial Silver Nanoparticles for Wound Healing Application: Progress and Future Trends
Federica Paladini,Mauro Pollini +1 more
TL;DR: This review aims at providing the reader with an overview of the most recent progress in silver nanotechnology, with a special focus on the role of silver in the wound healing process.
Journal ArticleDOI
Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganisms.
Gebreselema Gebreyohannes,Gebreselema Gebreyohannes,Andrew Nyerere,Christine Bii,Desta Berhe Sbhatu +4 more
TL;DR: Boprospecting for quorum quenching compounds can be an appropriate solution for controlling biofilm infections, according to a review of recent research and review articles.
Journal ArticleDOI
Recent developments in smart antibacterial surfaces to inhibit biofilm formation and bacterial infections
Xi Li,Biao Wu,Hao Chen,Hao Chen,Kaihui Nan,Kaihui Nan,Yingying Jin,Lin Sun,Bailiang Wang,Bailiang Wang +9 more
TL;DR: In this article, the authors discuss the recent progress in biofilm interference and smart antibacterial surfaces and discuss the major topics discussed are: (i) smart anti-biofilm surfaces via the prevention of biofilm formation or promoting mature biofilm dissolution, (ii) smart materials for reversible killing and/or release of bacteria, (iii) smart surfaces responsive to bacterial infection microenvironments or external stimuli and (iv) bio-inspired surfaces with antifouling and bactericidal properties.
References
More filters
Journal ArticleDOI
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
Leonard A. Mermel,Michael Allon,Emilio Bouza,Donald E. Craven,Patricia M. Flynn,Issam I Raad,Bart J. A. Rijnders,Robert J. Sherertz,David K. Warren,North Carolina +9 more
TL;DR: These updated guidelines replace the previous management guidelines published in 2001 and are intended for use by health care providers who care for patients who either have these infections or may be at risk for them.
Journal ArticleDOI
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
TL;DR: The results suggest that all three major classes of bactericidal drugs can be potentiated by targeting bacterial systems that remediate hydroxyl radical damage, including proteins involved in triggering the DNA damage response, e.g., RecA.
Journal ArticleDOI
Quantification of biofilm structures by the novel computer program COMSTAT.
Arne Heydorn,Alex Toftgaard Nielsen,Morten Hentzer,Claus Sternberg,Michael Givskov,Bjarne Kjær Ersbøll,Søren Molin +6 more
TL;DR: Analysis of biofilms of P. aureofaciens growing on 0.03 mM, 0.1 mM or 0.5 mM citrate minimal media showed that mean biofilm thickness increased with increasing citrate concentration, whereas surface to volume ratio increased with higher citrate concentrations.
Journal ArticleDOI
The Calgary Biofilm Device: New Technology for Rapid Determination of Antibiotic Susceptibilities of Bacterial Biofilms
TL;DR: Minimal biofilm eradication concentrations, derived by using the Calgary Biofilm Device, demonstrated that for biofilms of the same organisms, 100 to 1,000 times the concentration of a certain antibiotic were often required for the antibiotic to be effective, while other antibiotics were found to beeffective at the MICs.
Journal ArticleDOI
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
TL;DR: Determination of spontaneous mutation rates in 128 P. aeruginosa isolates from 30 CF patients revealed that 36% of the patients were colonized by a hypermutable (mutator) strain that persisted for years in most patients, revealing a link between high mutations rates in vivo and the evolution of antibiotic resistance.